Edition:
United Kingdom

Paion AG (PA8G.DE)

PA8G.DE on Xetra

2.45EUR
17 Aug 2018
Change (% chg)

€0.12 (+5.15%)
Prev Close
€2.33
Open
€2.34
Day's High
€2.50
Day's Low
€2.34
Volume
57,211
Avg. Vol
45,312
52-wk High
€2.98
52-wk Low
€2.01

Chart for

About

Paion AG is a Germany-based biopharmaceutical company. The Company's main product is remimazolam, an intravenous ultra-short-acting benzodiazepine sedative and anesthetic. In the human body, remimazolam is metabolized to an inactive metabolite by tissue esterase and not metabolized by cytochrome-dependent hepatic pathways. In... (more)

Overall

Beta: 0.77
Market Cap(Mil.): €162.82
Shares Outstanding(Mil.): 61.12
Dividend: --
Yield (%): --

Financials

  PA8G.DE Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -0.24 -- --
ROI: -46.05 1.78 14.61
ROE: -46.08 3.28 16.33

BRIEF-Paion FY Net Loss At EUR 12.1 Million

* SAYS CASH AND CASH EQUIVALENTS OF EUR 24.8 MILLION AS OF 31 DECEMBER 2017

22 Mar 2018

Earnings vs. Estimates